📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53. (2018)

First Author: Madan E

Attributed to: Structural biology of the tumour suppressor p53 and its complexes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1074/jbc.ra117.000950

PubMed Identifier: 29382728

Publication URI: http://europepmc.org/abstract/MED/29382728

Type: Journal Article/Review

Volume: 293

Parent Publication: The Journal of biological chemistry

Issue: 12

ISSN: 0021-9258